Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

China flag China · Delayed Price · Currency is CNY
37.60
+0.17 (0.45%)
Jan 22, 2026, 3:00 PM CST
5.83%
Market Cap11.88B
Revenue (ttm)1.90B
Net Income (ttm)498.69M
Shares Out316.05M
EPS (ttm)1.61
PE Ratio23.33
Forward PE17.68
Dividend0.64 (1.72%)
Ex-Dividend Daten/a
Volume1,832,824
Average Volume3,991,210
Open37.54
Previous Close37.43
Day's Range37.35 - 37.69
52-Week Range29.86 - 50.86
Beta0.44
RSI43.49
Earnings DateApr 30, 2026

About SHA:688076

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 2,028
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688076
Full Company Profile

Financial Performance

In 2024, SHA:688076's revenue was 1.62 billion, an increase of 57.21% compared to the previous year's 1.03 billion. Earnings were 404.39 million, an increase of 148.19%.

Financial Statements